Recombinant Human Anti-S. aureus Antibody (LTM14) (CAT#: PABX-167)

Anti-S. aureus antibody is a Human antibody of IgG class that binds to an S. aureus. It developed From a human scFv phage library.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Block

Figure 1 Blocking activity of antibodies against α-hemolysin in human serum samples and in vitro neutralizing activity of LTM14.

Figure 1 Blocking activity of antibodies against α-hemolysin in human serum samples and in vitro neutralizing activity of LTM14.

Foletti, D., Strop, P., Shaughnessy, L., Hasa-Moreno, A., Casas, M. G., Russell, M., ... & Pons, J. (2013). Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. Journal of molecular biology, 425(10), 1641-1654.

Block

Figure 2 LTM14 dose-dependently blocks the lytic activity of α-hemolysin on REs.

Figure 2 LTM14 dose-dependently blocks the lytic activity of α-hemolysin on REs.

Foletti, D., Strop, P., Shaughnessy, L., Hasa-Moreno, A., Casas, M. G., Russell, M., ... & Pons, J. (2013). Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. Journal of molecular biology, 425(10), 1641-1654.

FuncS

Figure 3 In vivo efficacy of LTM14 in a mouse model of S. aureus pneumonia, prophylactic antibody administration.

Figure 3 In vivo efficacy of LTM14 in a mouse model of S. aureus pneumonia, prophylactic antibody administration.

Survival curves for groups of mice dosed with LTM14 (30 mg/kg ip) or vehicle before intranasal challenge with 3.2 x 10⁸ CFU of S. aureus USA300 LAC.

Foletti, D., Strop, P., Shaughnessy, L., Hasa-Moreno, A., Casas, M. G., Russell, M., ... & Pons, J. (2013). Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. Journal of molecular biology, 425(10), 1641-1654.

FuncS

Figure 4 In vivo efficacy of LTM14 in a mouse model of S. aureus pneumonia, therapeutic antibody administration and combination with linezolid.

Figure 4 In vivo efficacy of LTM14 in a mouse model of S. aureus pneumonia, therapeutic antibody administration and combination with linezolid.

Survival curves for groups of mice dosed with either 30 mg/kg LTM14 or 12 mg/kg linezolid 12 and 18 h after intranasal challenge with 5x 10⁸ CFU of S. aureus USA300 LAC.

Foletti, D., Strop, P., Shaughnessy, L., Hasa-Moreno, A., Casas, M. G., Russell, M., ... & Pons, J. (2013). Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. Journal of molecular biology, 425(10), 1641-1654.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG
  • Specificity
  • Tested positive against native S. aureus
  • Species Reactivity
  • Staphylococcus aureus
  • Clone
  • LTM14
  • Applications
  • Block, FuncS

Product Property

  • Purity
  • >95% by SDS-PAGE and HPLC analysis
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • This antibody has been reported for use in Functional Assay and Blocking. It's recommended that the optimal antibody concentration, dilution, incubition time, etc. should be carefully titrated in specific assays.

Target

  • Alternative Names
  • S. aureus; Staphylococcus aureus

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone LTM14"

See other products for "S. aureus"

Single-domain Antibody

CAT Product Name Application Type
NABL-033 Recombinant Anti-S. aureus VHH Single Domain Antibody WB, ELISA, IP, FuncS Llama VHH

Humanized Antibody

CAT Product Name Application Type
PABX-167-S (P) Recombinant Human Anti-S. aureus Antibody scFv Fragment (LTM14) Neut, ELISA, FuncS scFv

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABX-167. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare